Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-zidocapt (Hydrochlorothiazide/captopril)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-zidocapt 25mg/50mg tablets
0205051G0AAAAAA
|
Co-zidocapt | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | 1 |
|
Acezide 25mg/50mg tablets
0205051G0BBAAAA
|
Acezide | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
Capozide 25mg/50mg tablets
0205051G0BCAAAA
|
Capozide | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
Capozide LS 12.5mg/25mg tablets
0205051G0BCABAB
|
Capozide | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
Co-zidocapt 12.5mg/25mg tablets
0205051G0AAABAB
|
Co-zidocapt | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.